Overview

The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Azithromycin